GlassScriptPhysician profile
Vishu Lammata
NPI 1811181134
$5,138.79
in general payments reported to CMS, 2019-2025
24 companies · $543 in 2025
The $543 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,404 · 2020: $369 · 2021: $232 · 2022: $640 · 2023: $594 · 2024: $357 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,494.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,676.28 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Biotronik INC. | $621.87 | 2019-2023 | Orsiro Mission |
| Edwards Lifesciences Corporation | $424.71 | 2022-2024 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $416.56 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $288.86 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $285.26 | 2019 | |
| Kestra Medical Technology Services, INC. | $276.22 | 2025 | Assure Wcd |
| Bolton Medical INC | $198.26 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Thoraflex Hybrid |
| Janssen Pharmaceuticals, INC | $162.07 | 2019-2022 | |
| Amgen INC. | $135.73 | 2019-2021 | |
| Philips North America LLC | $133.12 | 2020-2022 | |
| Amarin Pharma, INC. | $126.82 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $80.56 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.22 | 2019-2021 | |
| Stryker Corporation | $46.98 | 2025 | Flowtriever |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.62 | 2021-2022 | |
| Medtronic, INC. | $28.18 | 2024 | Corevalve Evolut R |
| Bardy Diagnostics, INC. | $25.00 | 2019 | |
| Vital Connect, INC | $21.87 | 2025 | Vitalpatch Rtm |
| Merck Sharp & Dohme LLC | $21.81 | 2021 | |
| Abbott Laboratories | $14.78 | 2020 | |
| Novo Nordisk INC | $13.13 | 2024 | Ozempic |
| Arbor Pharmaceuticals, INC. | $13.09 | 2021 | |
| Allergan, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishu Lammata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.